372 related articles for article (PubMed ID: 29139091)
21. Modern Management of Perianal Crohn's Disease: A Review.
Williams JL; Shaffer VO
Am Surg; 2021 Sep; 87(9):1361-1367. PubMed ID: 33345571
[TBL] [Abstract][Full Text] [Related]
22. Managing perianal Crohn's fistula in the anti-TNFα era.
Tozer P; Borowski DW; Gupta A; Yassin N; Phillips R; Hart A
Tech Coloproctol; 2015 Nov; 19(11):673-8. PubMed ID: 26264168
[TBL] [Abstract][Full Text] [Related]
23. Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn's disease: a Brazilian multicenter observational study.
Kotze PG; Albuquerque IC; da Luz Moreira A; Tonini WB; Olandoski M; Coy CS
Arq Gastroenterol; 2014; 51(4):284-9. PubMed ID: 25591155
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center.
Bor R; Farkas K; Bálint A; Szucs M; Ábrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
Scand J Gastroenterol; 2015 Feb; 50(2):182-7. PubMed ID: 25384713
[TBL] [Abstract][Full Text] [Related]
25. Surgical repair and biological therapy for fecal incontinence in Crohn's disease involving both sphincter defects and complex fistulas.
Alvarez JA; Bermejo F; Algaba A; Hernandez MP; Grau M
J Crohns Colitis; 2011 Dec; 5(6):598-607. PubMed ID: 22115381
[TBL] [Abstract][Full Text] [Related]
26. Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial.
de Groof EJ; Buskens CJ; Ponsioen CY; Dijkgraaf MG; D'Haens GR; Srivastava N; van Acker GJ; Jansen JM; Gerhards MF; Dijkstra G; Lange JF; Witteman BJ; Kruyt PM; Pronk A; van Tuyl SA; Bodelier A; Crolla RM; West RL; Vrijland WW; Consten EC; Brink MA; Tuynman JB; de Boer NK; Breukink SO; Pierik MJ; Oldenburg B; van der Meulen AE; Bonsing BA; Spinelli A; Danese S; Sacchi M; Warusavitarne J; Hart A; Yassin NA; Kennelly RP; Cullen GJ; Winter DC; Hawthorne AB; Torkington J; Bemelman WA
Trials; 2015 Aug; 16():366. PubMed ID: 26289163
[TBL] [Abstract][Full Text] [Related]
27. Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.
Bouchard D; Abramowitz L; Bouguen G; Brochard C; Dabadie A; de Parades V; Eléouet-Kaplan M; Fathallah N; Faucheron JL; Maggiori L; Panis Y; Pigot F; Rouméguère P; Sénéjoux A; Siproudhis L; Staumont G; Suduca JM; Vinson-Bonnet B; Zeitoun JD
Tech Coloproctol; 2017 Sep; 21(9):683-691. PubMed ID: 28929282
[TBL] [Abstract][Full Text] [Related]
28. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
29. Perianal Crohn's disease.
Khaikin M; Chowers Y; Zmora O
Isr Med Assoc J; 2007 Mar; 9(3):163-8. PubMed ID: 17402327
[TBL] [Abstract][Full Text] [Related]
30. Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn's disease.
Yassin NA; Askari A; Warusavitarne J; Faiz OD; Athanasiou T; Phillips RK; Hart AL
Aliment Pharmacol Ther; 2014 Oct; 40(7):741-9. PubMed ID: 25115149
[TBL] [Abstract][Full Text] [Related]
31. Combined Medical and Surgical Approach Improves Healing of Septic Perianal Crohn's Disease.
Choi CS; Berg AS; Sangster W; Schieffer KM; Harris LR; Deiling SM; Koltun WA
J Am Coll Surg; 2016 Sep; 223(3):506-514.e1. PubMed ID: 27266825
[TBL] [Abstract][Full Text] [Related]
32. The long-term outcome of anti-TNF alpha therapy in perianal Crohn's disease.
Rayen J; Currie T; Gearry RB; Frizelle F; Eglinton T
Tech Coloproctol; 2017 Feb; 21(2):119-124. PubMed ID: 28066859
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's Disease.
Taxonera C; Barreiro-de-Acosta M; Bastida G; Martinez-Gonzalez J; Merino O; García-Sánchez V; Gisbert JP; Marín-Jiménez I; López-Serrano P; Gómez-García M; Iglesias E; Lopez-Sanroman A; Chaparro M; Saro C; Bermejo F; Pérez-Carazo L; Plaza R; Olivares D; Alba C; Mendoza JL; Fernández-Blanco I
J Crohns Colitis; 2016 Jun; 10(6):657-62. PubMed ID: 26786982
[TBL] [Abstract][Full Text] [Related]
34. Fistulizing Crohn's disease.
Felley C; Mottet C; Juillerat P; Pittet V; Froehlich F; Vader JP; Michetti P; Gonvers JJ
Digestion; 2007; 76(2):109-12. PubMed ID: 18239401
[TBL] [Abstract][Full Text] [Related]
35. [Perianal fistulas in Crohn's disease--biologicals and surgery: is it worthwhile?].
Bode M; Eder S; Schürmann G
Z Gastroenterol; 2008 Dec; 46(12):1376-83. PubMed ID: 19053007
[TBL] [Abstract][Full Text] [Related]
36. Medical management of perianal Crohn's disease.
Winter AM; Hanauer SB
Semin Gastrointest Dis; 1998 Jan; 9(1):10-4. PubMed ID: 9547851
[TBL] [Abstract][Full Text] [Related]
37. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure.
Echarri A; Castro J; Barreiro M; Carpio D; Pereira S; Lorenzo A
J Crohns Colitis; 2010 Dec; 4(6):654-60. PubMed ID: 21122576
[TBL] [Abstract][Full Text] [Related]
39. Biological immunomodulators improve the healing rate in surgically treated perianal Crohn's fistulas.
El-Gazzaz G; Hull T; Church JM
Colorectal Dis; 2012 Oct; 14(10):1217-23. PubMed ID: 22251452
[TBL] [Abstract][Full Text] [Related]
40. Local injection of adalimumab for perianal Crohn's disease: better than infliximab?
Poggioli G; Laureti S; Pierangeli F; Bazzi P; Coscia M; Gentilini L; Gionchetti P; Rizzello F
Inflamm Bowel Dis; 2010 Oct; 16(10):1631. PubMed ID: 20848458
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
